» Articles » PMID: 21836255

The Development of Stable Aqueous Suspensions of PEGylated SPIONs for Biomedical Applications

Overview
Journal Nanotechnology
Specialty Biotechnology
Date 2011 Aug 13
PMID 21836255
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We report here the development of stable aqueous suspensions of biocompatible superparamagnetic iron oxide nanoparticles (SPIONs). These so-called ferrofluids are useful in a large spectrum of modern biomedical applications, including novel diagnostic tools and targeted therapeutics. In order to provide prolonged circulation times for the nanoparticles in vivo, the initial iron oxide nanoparticles were coated with a biocompatible polymer poly(ethylene glycol) (PEG). To permit covalent bonding of PEG to the SPION surface, the latter was functionalized with a coupling agent, 3-aminopropyltrimethoxysilane (APS). This novel method of SPION PEGylation has been reproduced in numerous independent preparations. At each preparation step, particular attention was paid to determine the physico-chemical characteristics of the samples using a number of analytical techniques such as atomic absorption, Fourier transform infrared (FT-IR) spectroscopy and Raman spectroscopy, transmission electron microscopy (TEM), photon correlation spectroscopy (PCS, used for hydrodynamic diameter and zeta potential measurements) and magnetization measurements. The results confirm that aqueous suspensions of PEGylated SPIONs are stabilized by steric hindrance over a wide pH range between pH 4 and 10. Furthermore, the fact that the nanoparticle surface is nearly neutral is in agreement with immunological stealthiness expected for the future biomedical applications in vivo.

Citing Articles

Enhanced Delivery and Potency of Chemotherapeutics in Melanoma Treatment via Magnetite Nanobioconjugates.

Diaz E, Quezada V, Cifuentes J, Arias Morales N, Reyes L, Munoz-Camargo C ACS Omega. 2024; 9(45):45402-45420.

PMID: 39554413 PMC: 11561594. DOI: 10.1021/acsomega.4c07415.


Specific nanoprobe design for MRI: Targeting laminin in the blood-brain barrier to follow alteration due to neuroinflammation.

Zapata-Acevedo J, Losada-Barragan M, Osma J, Cruz J, Reiber A, Petry K PLoS One. 2024; 19(4):e0302031.

PMID: 38603692 PMC: 11008835. DOI: 10.1371/journal.pone.0302031.


Cubic Mesocrystal Magnetic Iron Oxide Nanoparticle Formation by Oriented Aggregation of Cubes in Organic Media: A Rational Design to Enhance the Magnetic Hyperthermia Efficiency.

Egea-Benavente D, Diaz-Ufano C, Gallo-Cordova A, Palomares F, Cuya Huaman J, Barber D ACS Appl Mater Interfaces. 2023; 15(27):32162-32176.

PMID: 37390112 PMC: 10347427. DOI: 10.1021/acsami.3c03254.


Tailoring Magnetite-Nanoparticle-Based Nanocarriers for Gene Delivery: Exploiting CRISPRa Potential in Reducing Conditions.

Arango D, Cifuentes J, Puentes P, Beltran T, Bittar A, Ocasion C Nanomaterials (Basel). 2023; 13(11).

PMID: 37299685 PMC: 10254418. DOI: 10.3390/nano13111782.


Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells.

Eljack S, Allard-Vannier E, Misericordia Y, Herve-Aubert K, Aubrey N, Chourpa I Pharmaceutics. 2022; 14(11).

PMID: 36432729 PMC: 9696063. DOI: 10.3390/pharmaceutics14112537.